| Enrollment | Baseline | Mediastinoscopy | 1 W after mediastinoscopy | Therapy | 2 W after start treatmenta | 4 W after start treatmenta | 3 M after start treatmenta | 6 M after start treatmenta | 12 M after start treatmenta | 24 M after start treatmenta |
---|---|---|---|---|---|---|---|---|---|---|---|
 | T0 | T1 | T2 | T3 | T4 | T5 | T6 | T7 | T8 | T9 | |
Informed consent | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Baseline data | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â |
eCRF EBUS/EUS | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â |
eCRF Mediastinoscopy | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â |
eCRF PA Mediastinoscopy | Â | Â | Â | X | Â | Â | Â | Â | Â | Â | Â |
eCRF Therapy | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | Â |
eCRF PA Surgery | Â | Â | Â | Â | Â | X | Â | Â | Â | Â | Â |
eCRF Follow-upb | Â | Â | Â | X | Â | X | Â | X | X | X | X |
EQ-5D-5Â L | Â | + | Â | + | Â | + | + | + | + | + | + |
EORTC QLQ-C30 | Â | + | Â | + | Â | + | + | + | + | + | + |
EORTC QLQ-LC13 | Â | + | Â | + | Â | + | + | + | + | + | + |
iMTA – iMCQ |  | + |  |  |  |  | + | + | + | + | + |
iMTA – iPCQ |  | + |  |  |  |  | + | + | + | + | + |
 |  | Wave 1 |  | Wave 2 |  | Wave 3 | Wave 4 | Wave 5 | Wave 6 | Wave 7 | Wave 8 |